Dr. Danielle M. McMechan, MD

Dr. McMechan practices at Regional Eye Surgery Center - Baton Rouge in Baton Rouge, Louisiana.

Dr. McMechan's NPI, 1528486883, was assigned on April 3, 2014. Dr. McMechan holds Louisiana license 327741.

Dr. McMechan's primary practice is Regional Eye Surgery Center - Baton Rouge, at 7777 Hennessey Blvd, Suite 5000, Baton Rouge, LA 70808. The practice phone is (225) 214-6688.

Dr. McMechan's primary practice is Regional Eye Surgery Center - Baton Rouge in Baton Rouge, Louisiana. Dr. McMechan is also affiliated with Our Lady of the Lake Regional Medical Center. The medical group on file is Our Lady of the Lake Physician Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McMechan practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. McMechan's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. McMechan's licenses on file in 2 states: Louisiana and Kentucky.

CMS data shows 89 Medicare services from Dr. McMechan across 3 procedure codes in 2024, for 41 Medicare patients. Medicare paid $7,470 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 41 Medicare patients who saw Dr. McMechan in 2024. The largest group is 65 to 74, with 18 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 51% are also on Medicaid. Their average risk score is 2.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McMechan's median patient age at 68, with 53% women.

In 2024, Dr. McMechan wrote 127 Medicare Part D claims for 62 patients. 82% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $120 in total drug cost. In 2022, CMS named 140 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. McMechan for performance year 2024, reported as part of a group. Dr. McMechan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McMechan as offering telehealth.

Dmand AI links 2 papers to Dr. McMechan. The most frequent topics are Colonoscopy, Colorectal Neoplasms and Early Detection of Cancer. Dr. McMechan has published most often in Am Fam Physician. Dr. McMechan's most frequent co-authors are Asif M. Talukder, MD and Alan Herline, MD.

CMS Open Payments shows 17 general payments to Dr. McMechan from 8 drug and device companies from 2018 to 2023. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $109.